Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H1N1 Vaccine in HIV-Infected Children and Youth
NCT00992836Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Oct 2009
- Primary completion
- Aug 2010
- Modality
- Live Attenuated Vaccines, Whole Inactivated Vaccines
- Countries
- 2
01
Overview
A Phase 2 trial of Influenza A (H1N1) vaccine in H1N1 influenza (H1N1), sponsored by National Institute of Allergy and Infectious Diseases. Started Oct 2009; status: completed.
02
Drugs
Influenza A (H1N1) vaccine
03
Conditions
H1N1 influenza (H1N1)
Beyond the preview
Go deeper on NCT00992836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00992836.